Background: Urinary tract infections are among the most common human infections. Due to the progressive increase in ESBL-producing bacteria and the unavailability of new antibiotics, re-evaluation of 'old' antibiotics is needed. However, the pharmacodynamics of nitrofurantoin under variable pH conditions are poorly understood. We determined the pharmacodynamic properties of nitrofurantoin at different pH levels using time-kill assays.
Introduction
Nitrofurantoin is a broad-spectrum bactericidal antibiotic and has been used clinically for .50 years. 1 A continuing increase in antibiotic resistance in Gram-negative ESBL-producing bacteria and the limited availability of new antibiotics has renewed interest in and re-evaluation of nitrofurantoin for the treatment of urinary tract infections (UTIs). [2] [3] [4] [5] Bacterial susceptibility is measured in the laboratory under standardized conditions. 6 However, success of antibiotic treatment depends not only on the susceptibility of bacteria but also on external factors. Whereas the internal environment is reasonably constant, this is not true for urine. In particular, the pH may vary significantly. Normally urine is slightly acidic, with a pH 6, however, it can range from 4.5 to 8.6. 7 This pH balance is normally controlled by the body, but can be affected by food and beverage intake, certain disease processes such as UTIs, and medications such as ascorbic acid and sodium bicarbonate. 8, 9 A previous study by Yang et al. 10 suggested that an acidic environment might enhance the activity of nitrofurantoin. In their study nitrofurantoin susceptibility increased significantly for several strains at pH 6 compared with pH 7-8, with reductions in MIC ranging from 4-to 32-fold. Following our previous study describing the pharmacodynamics of nitrofurantoin on the species level, 11 we here focus on the effect of pH level in detail, including pharmacodynamic properties. In this present study nitrofurantoin pharmacodynamics were determined at four different pH levels against ESBL-producing Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae using time-kill assays.
Materials and methods

Bacterial isolates and antibiotics
Seven ESBL-producing isolates [E. coli (n " 4), K. pneumoniae (n " 2), E. cloacae (n " 1)] and two ESBL-negative isolates [one E. cloacae and one E. coli] with known MICs and genotypes were included in the study (Table 1) . Most isolates harboured CTX-M type b-lactamases together with other resistance genes (SHV, OXA or TEM); additional details are described elsewhere. 11, 12 Bacterial suspensions were prepared from plate cultures 16-24 h old in CAMHB (BD Bioscience, Erembodegem, Belgium) and adjusted to a turbidity equivalent to that of a 0.5 McFarland standard using a spectrophotometer.
Nitrofurantoin (CAS 67-20-9) was obtained from Molekula (Munich, Germany). A stock solution of 10240 mg/L was prepared freshly on the day of each experiment with DMSO as solvent. The desired working concentrations were obtained after appropriate dilution in pre-warmed pH-adjusted CAMHB bottles at four pH levels (5.5, 6.5, 7.5 and 8.5). The pH of all CAMHB was measured electronically under gentle stirring conditions at 37 C and adjusted with either hydrochloric acid or sodium hydroxide solutions.
Time-kill assay
Glass bottles of 20 mL containing CAMHB at four different pH levels (5.5, 6.5, 7.5 and 8.5) and 2-fold increasing concentrations of nitrofurantoin (from 0.125 to 32 % MIC) were prepared and kept in darkness until inoculation with 100 lL of a 0.5 McFarland bacterial suspension to reach a final concentration of 5%10 5 cfu/mL. The bottles were incubated in darkness at 37 C under shaking conditions (260 rpm) for 24 h. For each experiment a drug-free growth control was included.
To assess the effect of nitrofurantoin on bacterial growth, samples of 20 lL were taken from each bottle at selected time intervals (0, 1, 2, 3, 4, 6, 8, 16 and 24 h after the start of the experiment) and serial 10-fold dilutions in 0.9% saline solution in 96-well plates were prepared. Ten microlitres from each dilution and an undiluted sample were plated in triplicate on Mueller-Hinton agar plates (BD Bioscience, Erembodegem, Belgium). The cfu were counted after incubation for 20-24 h at 37 C. The lower limit of detection (LOD) was 33.3 cfu/mL per plate, corresponding to 1.52 log 10 cfu/ mL. The absence of growth after 24 h was regarded as complete kill.
Curve fitting and analysis
Viable bacterial count (cfu/mL) versus time curves were constructed for each strain. The bactericidal effects (3 log 10 cfu/mL reduction from initial inocula) and regrowth (increased growth after an initial cfu reduction) were assessed by visual inspection of time-kill curves for each strain and concentration. The Dlog 10 cfu/mL (change in log 10 cfu/mL from initial inocula) at 6 and 24 h timepoints were plotted against each log 10 -transformed concentration and analysed using Graphpad Prism 5.0 (Graphpad Inc., San Diego, CA, USA). The sigmoid maximum effect (E max ) model (four-parameter Hill equation) was fitted to the data, analysing each assay to determine the relationship between pH level and bacterial growth or kill. 13, 14 Geometric mean normalized by the MIC of the EC 50 , stasis (no cfu reduction compared with initial inoculum) and 1 and 3 log 10 cfu/mL kill at 6 and 24 h were calculated for each assay. For some strains e.g. 1 and/or 3 log kill was not achieved at a certain pH level and therefore left out of the equation.
Goodness of fit of the E max model was assessed using R 2 and a post-run test. The differences in the geometric mean of the pharmacodynamic parameters (EC 50 , C stasis , C 1logkill and C 3logkill ) at 6 and 24 h within the species between pH levels were assessed by one-way analysis of variance (ANOVA) followed by the Tukey-Kramer multiple comparison test.
Results
Effect of pH on bacterial (re)growth
For each strain 8-10 concentrations (depending on the MIC for the strain) were tested at pH 5.5, 6.5, 7.5 and 8.5. An example of representative time-kill curves of K. pneumoniae at the four different pH levels is shown in Figure 1 .
Over the first 6 h, growth rates in the drug-free controls appeared to differ for each of the four different pH levels. In general, the growth rates appeared to show an inverse U-shaped pattern with lower growth rates at the more extreme pH values for all three species. This is evidenced by mean growth rates of E. coli of 0.47, 0.55, 0.58 and 0.51 log 10 cfu/mL % h
#1
, respectively, and of 0.55, 0.59, 0.60 and 0.51 log 10 cfu/mL % h #1 , respectively, for K. pneumoniae. The effect of pH was even more pronounced in E. cloacae, with growth rates of 0.41 and 0.42 log 10 cfu/mL % h #1 at pH level 5.5 and 8.5, respectively, compared with 0.56-0.57 cfu/mL % h #1 at the intermediate pH levels 6.5 and 7.5. Of note, there was one exception for E. coli strain 3, showing the highest growth rate at pH 8.5.
Nevertheless, although growth rates differed by pH, the maximum bacterial count in the drug-free controls was similar for all pH levels, around 3.0%10 9 cfu/mL, and was observed within 8-16 h for all strains (data not shown).
Effect of pH on kill characteristics
Minimum bactericidal effects differed significantly by species and pH level.
For E. coli, at the lower pH levels (5.5-6.5) for all five isolates the bactericidal effect was observed at nitrofurantoin concentrations of 0.5 % MIC (equivalent to 8-16 mg/L for most strains) around 16 h. At pH 7.5 this effect was observed at 2 % MIC, whereas at pH 8.5 only the highest tested concentrations, 16 % MIC (128-256 mg/L), were bactericidal. Therefore, higher concentrations were required for a bactericidal effect at the higher pH levels. Thus, the killing of E. coli by nitrofurantoin decreased at higher pH, indicating a pH-dependent bactericidal activity.
For K. pneumoniae the activity of nitrofurantoin was lower compared with E. coli. Killing was slower and higher nitrofurantoin concentrations were required for a bactericidal effect. From pH 5.5 up to pH 7.5 concentrations of 2-4 % MIC (128 mg/L) were required and bactericidal effects were generally observed only after extended exposure of 8-16 h. Similar to E. coli, at pH 8.5 a bactericidal effect occurred only at the highest concentration, 256 mg/L. Pharmacodynamics of nitrofurantoin at different pH levels JAC However, this effect was not permanent and regrowth was observed for both K. pneumoniae strains. For E. cloacae, nitrofurantoin appeared to be as effective as for E. coli. At similar concentrations at the low pH levels, however, killing appeared to be much more concentration dependent and faster. For both E. cloacae strains, bactericidal effects were observed at concentrations of 0.5-1 % MIC (8-16 mg/L) and within 2-8 h dependent on the concentration tested. The effect of nitrofurantoin increased at higher nitrofurantoin concentrations, indicating a concentration-dependent bactericidal activity against E. cloacae. However, a decreasing trend in nitrofurantoin activity was observed with increasing pH in E. cloacae. At pH 8.5 regrowth occurred up to 8 % MIC (128 mg/L) for the ESBL strain, while for the ESBL-negative strain regrowth was only observed up to a concentration 2 % MIC (32 mg/L).
Overall, for almost all isolates at pH 8.5 only the two highest concentrations (8-32 % MIC depending on the isolate) were considered bactericidal, but complete bacterial clearance of the bottles was not permanent and regrowth was observed very frequently at high concentrations (128 mg/L).
Early (6 h) and late (24 h) pharmacodynamic modelling
The sigmoid E max model with variable slope showed a good fit to the change in log 10 cfu/mL versus concentration data (R 2 0.95) for all strains and pH levels at both the 6 and 24 h timepoints. Representative best-fit response curves for E. coli, K. pneumoniae and E. cloacae at various pH levels are shown in Figure 2 . At the highest pH (8.5) in both E. coli and K. pneumoniae the reduction in log 10 cfu/mL was decreased compared with the lower tested pH levels. At the lower pH levels (5.5-6.5) in general a maximal reduction of 2.5 log 10 cfu/mL was reached. However, at pH 5.5 for K. pneumoniae strain 58 a reduction of almost 4 log 10 cfu/mL was observed. At all four pH levels within the first 6 h E. cloacae showed larger decreases in population size (.3-4 log 10 cfu/mL reduction) compared with the other species.
After 24 h the kill was maximal for almost all strains and was around 4.5 log 10 cfu/mL reduction for all strains with the exception of the Klebsiella strains at pH 8.5 (around 2.5-3 log 10 cfu/mL). At the 6 h analysis the bactericidal effect of nitrofurantoin appeared to be increased at higher concentrations in E. cloacae, indicating a concentration-dependent effect, while for E. coli the killing did not increase significantly at higher concentrations, thereby indicating a concentration-independent effect. However, at 24 h the effects appeared to be fading.
The relationship between pH and the parameters describing the pharmacodynamic characteristics are shown in Figure 3 and Tables 2 and 3 for the 6 and 24 h timepoints. To allow better comparison of the results between strains, the parameters were normalized by MIC and are thus presented as ratios: EC 50 /MIC, C stasis /MIC, C 1logkill /MIC and C 3logkill /MIC. Fransen et al.
Effect of pH on EC 50 and stasis normalized by MIC
Significant pH-dependent effects in overall geometric mean for EC 50 /MIC and C stasis /MIC were observed at 6 h for one species. At the end of the experiments the effect of pH level became more pronounced for several species. At 6 h, pH 5.5-6.5 and 7.5 required significantly lower concentrations (9-12% and 4.5% lower, respectively) compared with pH 8.5 (P , 0.0001) in E. coli. However, similar concentrations were required at pH 5.5, 6.5 or 7.5 to reach these effects for K. pneumoniae.
After 24 h for both EC 50 and C stasis the pH effects were even stronger and more pronounced. At pH 5.5-6.5 and 7.5 E. coli required 16.5% and 7.5% lower concentrations, respectively, compared with pH 8.5. For K. pneumoniae the concentrations were 3-5% and 2-3% lower, respectively, at these pH levels compared with pH 8.5.
For E. cloacae a clear increasing trend with increasing pH was observed for EC 50 /MIC and C stasis /MIC at the two timepoints . Approximately 6-10% (6 h) and 11% (24 h) higher concentrations were needed to reach these effects at pH 8.5; nevertheless, the normalized means were never considered significant.
To summarize, already after 6 h significant pH-dependent effects were observed for E. coli, and at 24 h the pH effects were more pronounced and significantly lower concentrations of nitrofurantoin were also needed for K. pneumoniae to reach either 50% or stasis compared with the highest pH (8.5). Although for Typical examples of best-fit sigmoid curves obtained from the sigmoid E max model exposed to nitrofurantoin at different pH levels at 6 and 24 h for E. coli strain 3, K. pneumoniae strain 58 and E. cloacae strain 32. A different y-axis scale is used for E. cloacae strain 32.
Pharmacodynamics of nitrofurantoin at different pH levels JAC E. cloacae strong increasing trends were observed with increasing pH level, the differences were never considered significant.
Effect of pH on 1 and 3 log kill normalized by MIC
When exposed for 6 h to nitrofurantoin not all strains and pH levels reached 1 and/or 3 log kill. For E. coli strain 39, 1 log kill was not achieved at pH 7.5 and 8.5; 3 log kill was, however, only reached for K. pneumoniae strain 58 (pH 5.5) and for E. cloacae with the exception of strain 94 (pH 8.5). At 6 h for all species a significant overall geometric mean difference between the four pH levels was observed. For both E. coli and K. pneumoniae, pH 5.5, 6.5 and 7.5 C 1logkill /MIC values were significantly lower compared with pH 8.5. Although a strong increase in concentration with increasing in pH level was observed for E. cloacae, only the comparison of pH 5.5 versus 8.5 was considered significant.
At 24 h E. coli required significantly lower concentrations (P , 0.0001) at pH 5.5, 6.5 and 7.5 versus 8.5 as well as 5.5 and 6.5 versus 7.5 to achieve either 1 or 3 log kill. Also, K. pneumoniae required significantly lower concentrations at pH 5.5, 6.5 and 7.5 versus 8.5 as well as 6.5 versus 7.5 to reach 1 log kill. The comparison of 3 log kill was not possible due to lack of observations at pH 6.5 (3 log kill was not reached). A strong increasing trend was visible for E. cloacae at pH 5.5 up to 8.5 (0.97, 2.01, 4.61 and 9.38 mg/L). This indicates that almost a 2.1%, 4.8% and 9.7% higher concentration is needed to reach 3 log kill for pH 6.5, 7.5 and 8.5, respectively, compared with pH 5.5; however, no statistical comparisons could be made.
To summarize, significant pH-dependent (lower pH versus pH 8.5) effects on the average concentration (normalized by MIC) to reach EC 50 , stasis or 1 log kill were already observed at 6 h for all three species. At 24 h the pH-dependent effects became even more pronounced. Although for E. cloacae a concentration- Fransen et al. Pharmacodynamics of nitrofurantoin at different pH levels JAC dependent trend was visible for both the 1 and 3 log kill comparisons of the different pH levels, significance was never reached.
Discussion
This study evaluated the effect of different pH levels on growth/kill patterns and described the basic pharmacodynamic properties of nitrofurantoin used to treat urinary tract infections caused by ESBL-producing E. coli, K. pneumoniae and E. cloacae.
In this study we demonstrated that at low pH (5.5-6.5) concentrations of 0.5 % MIC were already considered bactericidal for E. coli and E. cloacae. However, at pH 8.5 only the highest nitrofurantoin concentrations were considered bactericidal at some point in time. Nevertheless, bacterial clearance was not permanent at pH 8.5 and regrowth was observed very frequently up to high concentrations. Ertan et al. 15 investigated the degradation and stability of nitrofurantoin in extreme acidic (pH 1.2) and alkaline (pH 10) media and showed that the decrease in drug content of the alkaline medium was greater than that in the acidic medium. At 100 C nitrofurantoin was completely decomposed in the alkaline medium within 3 h. Although our medium was only slightly/moderately alkaline (pH 8.5) and the temperature only 37 C, it might be the case that the stability and activity of nitrofurantoin still was slightly reduced over time and therefore had some impact on the occurrence of the regrowth of bacteria at especially high pH levels. Besides, the major factor that has an effect on nitrofurantoin degradation is light. All experiments were therefore carried out in the dark and all flasks and tubes were protected from light.
Early-phase and late-phase pharmacodynamic modelling showed that E. coli required nitrofurantoin concentrations significantly lower (several times lower) for the different pharmacodynamic output parameters (50% or static effect and 1 and 3 log kill) at the lower pH levels (pH 5.5-6.5) compared with 7.5 and/or 8.5. Although for E. cloacae similar strong decreasing trends in required concentrations were visible with decreasing pH, none of the tested pharmacodynamic parameters was significant, with the exception of 1 log kill at 6 h. This is most likely due to the lack of observations and it is speculated that if the number of isolates were increased highly significant results would be obtained.
In our study we observed slightly different growth rates (U shaped pattern) over the four pH levels for most of the isolates and it might be possible that this difference influenced the kill/growth characteristics of nitrofurantoin at the more extreme pH values of 5.5 and 8.5.
Independent of pH level, a bactericidal effect was achieved much sooner in E. cloacae (2-8 h) compared with E. coli (around 16 h). This faster killing is in agreement with findings of previous research by Fransen et al.;
11 in those time-kill experiments, although performed in standard CAMHB without any pH adjustments (pH 7.3), a late bactericidal effect was observed for E. coli (12-16 h) while E. cloacae was already bactericidal within 4-8 h.
The clinical implications of these findings are related to the pHdependent activity of nitrofurantoin against Enterobacteriaceae, especially for E. coli, which is the most frequent causative organism in UTIs. 16, 17 Moreover, E. coli is the only species with clinical breakpoints, as other species are considered to be the cause of complicated UTIs. However, the use of nitrofurantoin in complicated UTIs is contraindicated because the tissue concentration of nitrofurantoin is considered too low to be effective. 18 Higher urinary pH (6.5) most likely decreases nitrofurantoin activity and as a consequence urinary tract infections may not resolve in a timely manner. Active lowering of urinary pH levels in patients with an alkaline urine might enhance killing and maximize the effectiveness of nitrofurantoin. It could therefore be beneficial to describe concomitant supplements that are capable of acidifying the urine, such as ascorbic acid or ammonium chloride in combination with nitrofurantoin.
Research performed in dogs indicated that a lower pH level resulted in higher tubular reabsorption in the kidneys and as a consequence lower urinary concentrations of nitrofurantoin were observed. 19 This indicates that not only pH level itself might be important but also nitrofurantoin urinary concentrations. However, in our experiments tubular reabsorption was not taken into account and therefore all nitrofurantoin concentrations were equal amongst the different tested pH levels.
In the initial experiments pH was re-measured after 24 h to determine whether changes occurred during the experiment. Some minor differences were observed (+0.3). However, compared with the pH effects we observed these were considered small and therefore it was decided not to adjust the pH during the 24 h time course of the experiments. pH changes during the experiment were therefore not likely to have an impact on our results. Besides, our experiments were performed in CAMHB, which is considered the worldwide standard for in vitro experiments and susceptibility testing. 6, 20 The MIC was determined in standard CAMHB (pH 7.3+0.2) according to EUCAST and all strains were considered susceptible to nitrofurantoin. However, since previous research showed 4-to 32-fold MIC reductions at pH 5 compared with higher pH and some strains even changed from resistant at pH 7 to susceptible at pH 5, it might be the case that lower MIC values would be observed if our strains were tested at different pH. 10 In addition, CAMHB has a different chemical composition compared with urine, and growth and kill kinetics may therefore differ in vivo, similar to other infections. 14 Direct extrapolation of the observed results to the in vivo situation is complicated. However, we expect that the observed effects of pH would still hold true. Further experiments under more physiological conditions are necessary to provide a better estimation of the actual influence of pH on the pharmacodynamics of nitrofurantoin in urine. Besides, the efficacy of nitrofurantoin depends not only on pH but also on virulence factors or capacity to form biofilms. 21 In summary, our findings show that nitrofurantoin activity, kill characteristics and E max parameters are significantly different at various pH levels, especially for E. coli and probably also for other species. Fransen et al.
